The current literature cannot conclude that fibroids reduce the likelihood of achieving pregnancy with or without fertility treatment based on a...
Providing equitable care calls for research, education, training, and targeted quality improvements
FDA and power morcellation, gel for vaginal odor, and an intrauterine electrosurgery system
FDA guidance for...
From the Editor
In many countries cesarean myomectomy is now viewed as a safe and effective procedure in carefully selected clinical situations
News for Your Practice
ACOG does not currently recommend antibiotics for myomectomy procedures. A retrospective study adds to the evidence, however,...
Be cognizant to follow these recommendations for minimizing the risk of viral spread during hysteroscopic procedures
From the Editor
Women with fibroids causing symptomatic abnormal uterine bleeding who choose to avoid a therapeutic procedure have a new hormonal treatment option...
Elagolix with hormonal add-back therapy (estradiol/norethindrone) was effective: 87.9% of participants who received...
Can a drug FDA approved for endometriosis become a mainstay for nonsurgical treatment of HMB in women with fibroids?
Elagolix is a GnRH antagonist that is approved in a 2-dose schedule for treatment of endometriosis. It is given...
Product update: Neuromodulation device, cystoscopy simplified, hysteroscopy seal, next immunization frontier
NEW SACRAL NEUROMODULATION DEVICE
Axonics Modulation Technologies, Inc. announced the first implantation of its recently US Food...